Synergy between CD26/DPP-IV Inhibition and G-CSF Improves Cardiac Function after Acute Myocardial InfarctionMarc‐Michael Zaruba, Wolfgang‐Michael Franz, Josef Mueller‐Hoecker et al.|Cell stem cell|2009Cited by 299
Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axisHans Theiß, Wolfgang-M. Franz, Yordan Vanchev et al.|Stem Cell Research|2011Cited by 111
Erythropoietin administration after myocardial infarction in mice attenuates ischemic cardiomyopathy associated with enhanced homing of bone marrow‐derived progenitor cells <i>via</i> the CXCR‐4/SDF‐1 axisStefan Brunner, Wolfgang‐Michael Franz, Josef Mueller‐Hoecker et al.|The FASEB Journal|2008Cited by 89
Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survivalMarc‐Michael Zaruba, Wolfgang‐Michael Franz, Josef Mueller‐Hoecker et al.|Cardiovascular Research|2007Cited by 76
Parathyroid hormone is a DPP-IV inhibitor and increases SDF-1-driven homing of CXCR4+ stem cells into the ischaemic heartBruno Hüber, Wolfgang‐Michael Franz, Petra Nathan et al.|Cardiovascular Research|2011Cited by 66